Dr Abdelrahman Ali is a cardiology fellow at the University of Texas Medical Branch (UTMB) in Galveston, with advanced training in cardio-oncology from The University of Texas MD Anderson Cancer Center. His research focuses on cancer therapy–related cardiac dysfunction, immune checkpoint inhibitor–associated myocarditis, and heart failure management in oncology populations. His work has been published in JACC: CardioOncology, European Heart Journal, Cardio-Oncology and Journal of Nuclear Cardiology.